An act concerning diabetes and high deductible health plans. This act (1) requires pharmacists, in certain emergency situations, to prescribe and dispense to a patient up to a 30-day supply of certain diabetesrelated drugs and devices once in a 12-month period; (2) limits how much pharmacists can charge for the emergency drugs and supplies in these situations; and (3) expands the state’s prescription drug monitoring program to include them
(§§ 3 & 5). The act requires the Department of Consumer Protection (DCP) commissioner to notify each retail pharmacy about these emergency drugs and devices requirements by October 1, 2020 (§ 4). Under the act, certain health insurance policies must do the following:
1. expand coverage for diabetes screening, drugs, and devices;
2. limit out-of-pocket costs (e.g., coinsurance, copayments, and deductibles) for covered diabetes-related drugs and devices; and
3. cover emergency diabetes-related drugs and devices prescribed and dispensed by a pharmacist under the act’s provisions (§§ 13-14).